Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Raymond James Financial Inc. purchased a new position in T. Rowe Price Ultra Short-Term Bond ETF (NYSEARCA:TBUX – Free Report ...

VictoryShares Free Cash Flow ETF (NASDAQ:VFLO – Get Free Report) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 432,600 shares ...

A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly misleading ...

Stifel analyst Chris O’Cull downgraded Xponential Fitness (XPOF) to Hold from Buy with a price target of $12, down from $20. The firm says it ...

Fintel reports that on February 27, 2025, Stifel downgraded their outlook for Arko (NasdaqCM:ARKO) from Buy to Hold. Analyst ...

Neumora Therapeutics (NASDAQ:NMRA) fell ~11% in the premarket on Friday as Stifel downgraded the biotech after efficacy concerns prompted J&J (NYSE:JNJ) to discontinue a late-stage program called ...

SAN DIEGO, March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18 ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Stifel Financial (SF) have what it takes? Let's find out.